Natural product fargesin interferes with H3 histone lactylation via targeting PKM2 to inhibit non‐small cell lung cancer tumorigenesis.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 592, doi. 10.1002/biof.2031
- By:
- Publication type:
- Article
Works matching IS 09516433 AND DT 2024 AND VI 50 AND IP 3
Results: 17
1
2
Erythrocytes' surface properties and stiffness predict survival and functional decline in ALS patients.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 558, doi. 10.1002/biof.2030
- By:
- Publication type:
- Article
3
PON1 has palmitoyl‐protein thioesterase (PPT) activity, and can affect the presence of SR‐B1 on the endothelial cell membrane.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 608, doi. 10.1002/biof.2029
- By:
- Publication type:
- Article
4
High‐fat diet induced obesity promotes inflammation, oxidative stress, and hepatotoxicity in female FVB/N mice.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 572, doi. 10.1002/biof.2028
- By:
- Publication type:
- Article
5
Epigallocatechin‐3‐gallate attenuates arsenic‐induced fibrogenic changes in human kidney epithelial cells through reversal of epigenetic aberrations and antioxidant activities.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 542, doi. 10.1002/biof.2027
- By:
- Publication type:
- Article
6
Correction to "Attenuative role of mangiferin in oxidative stress mediated liver dysfunction in arsenic intoxicated murines".
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 619, doi. 10.1002/biof.2026
- Publication type:
- Article
7
Extracellular vesicles (EVs): A promising therapeutic tool in the heart tissue regeneration.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 509, doi. 10.1002/biof.2025
- By:
- Publication type:
- Article
8
Melatonin protects Kir2.1 function in an oxidative stress‐related model of aging neuroglia.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 523, doi. 10.1002/biof.2024
- By:
- Publication type:
- Article
9
Glycosaminoglycan dermatan sulfate supplementation decreases diet‐induced obesity and metabolic dysfunction in mice.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 493, doi. 10.1002/biof.2022
- By:
- Publication type:
- Article
10
A glimpse into the structural properties of α‐synuclein oligomers.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 439, doi. 10.1002/biof.2021
- By:
- Publication type:
- Article
11
Investigating rutin as a potential transforming growth factor‐β type I receptor antagonist for the inhibition of bleomycin‐induced lung fibrosis.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 477, doi. 10.1002/biof.2020
- By:
- Publication type:
- Article
12
A new strategy for screening novel functional genes involved in reduction of lipid droplet accumulation.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 467, doi. 10.1002/biof.2019
- By:
- Publication type:
- Article
13
Dietary restriction alters insulin signaling pathway in the brain.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 450, doi. 10.1002/biof.2018
- By:
- Publication type:
- Article
14
Targeting stress granules in neurodegenerative diseases: A focus on biological function and dynamics disorders.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 422, doi. 10.1002/biof.2017
- By:
- Publication type:
- Article
15
Pax‐8: Molecular biology, pathophysiology, and potential pathogenesis.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 408, doi. 10.1002/biof.2016
- By:
- Publication type:
- Article
16
Issue Information ‐ Cover.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 1, doi. 10.1002/biof.1966
- Publication type:
- Article
17
Issue Information.
- Published in:
- Biofactors, 2024, v. 50, n. 3, p. 405, doi. 10.1002/biof.1965
- Publication type:
- Article